Invasive pneumococcal disease among children younger than 5 years of age before and after introduction of pneumococcal conjugate vaccine in Casablanca, Morocco

Isaacman, 2010, Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal vaccine and considerations for future conjugate vaccines, Int J Infect Dis, 14, e197, 10.1016/j.ijid.2009.05.010 2000, Preventing pneumococcal diseases among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP), MMWR Recomm. Rep, 49, 1 Johnson, 2010, Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project, PLoS Med, 5, 7 2012, World Health Organization (b): Pneumococcal conjugate vaccine for childhood immunization-WHO position paper, Wkly Epidemiol Rec, 87, 129 Linares, 2010, Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period, Clin Microbiol Infect, 16, 402, 10.1111/j.1469-0691.2010.03182.x Park, 2007, Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae, J Clin Microbiol, 45, 1225, 10.1128/JCM.02199-06 Jin, 2009, First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children, J Infect Dis, 200, 1375, 10.1086/606118 Calix, 2012, Differential occurrence of Streptococcus pneumoniae serotype 11E between asymptomatic carriage and invasive pneumococcal disease isolates reflects a unique model of pathogen microevolution, Clin Infect Dis, 54, 794, 10.1093/cid/cir953 Calix, 2012, Biochemical, genetic and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype, J BiolChem, 287, 27885 Hausdorff, 2000, Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I, Clin Infect Dis, 30, 100, 10.1086/313608 Robinson, 2001, Active Bacterial Core Surveillance (ABCs)/Emerging Infections Program Network. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995–1998: Opportunities for prevention in the conjugate vaccine era, JAMA, 285, 1729, 10.1001/jama.285.13.1729 Black, 2000, Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children, Pediatr Infect Dis J, 19, 187, 10.1097/00006454-200003000-00003 Song, 2013, Clinical Implications of Pneumococcal Serotypes: Invasive Disease Potential, Clinical Presentations, and Antibiotic Resistance, J Korean Med Sci, 28, 4, 10.3346/jkms.2013.28.1.4 Elmdaghri, 2012, Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco), Vaccine, 30, G46, 10.1016/j.vaccine.2012.10.044 2012 WHO Initiative for Vaccine Research Division. Acute respiratory infections, Streptococcus pneumoniae; September 2009. Available at: http://www.who.int/vaccine research/diseases/ari/en/index3.html (accessed 23.09.12). Harboe, 2010, Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades, Clin Infect Dis, 50, 329, 10.1086/649872 Hausdorff, 2005, Epidemiological differences among pneumococcal serotypes, Lancet Infect Dis, 2, 83, 10.1016/S1473-3099(05)70083-9 Iroh Tam, 2014, Invasive pneumococcal disease after implementation of 13-valent conjugate vaccine, Pediatrics, 134, 210, 10.1542/peds.2014-0473 Demczuk, 2013, Toronto Bacterial Diseases Network, Canadian Public Health Laboratory Network: Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010–2012, Can J Microbiol, 59, 778, 10.1139/cjm-2013-0614 Tan, 2012, Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines, Clin Microbiol Rev, 25, 409, 10.1128/CMR.00018-12 Burgos, 2011, The spectrum of pneumococcal empyema in adults in the early 21st century, Clin Infect Dis, 53, 254, 10.1093/cid/cir354 2010, Pediatrics, 126, 186, 10.1542/peds.2010-1280 dos Santos, 2013, Serotype distribution of Streptococcus pneumoniae isolated from patients with invasive pneumococcal disease in Brazil before and after ten-pneumococcal conjugate vaccine implementation, Vaccine, 31, 6150, 10.1016/j.vaccine.2013.05.042 Tyrrell, 2009, Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal conjugate vaccine introduction in Alberta, Canada, 2000–2006, Vaccine, 27, 3553, 10.1016/j.vaccine.2009.03.063 European Centre for Disease Prevention and Control: Annual Epidemiological Report 2012. Reporting on 2010 surveillance data and 2011 epidemic intelligence data. ECDC, Stockholm, Sweden. Available from http://www.ecdc.europa.eu/en/publications/Publications/Annual-Epidemiological-Report-2012.pdf [accessed 15 June 2013]. von Gottberg, 2014, GERMS-SA Investigators: Effects of vaccination on invasive pneumococcal disease in South Africa, N Engl J Med, 371, 1889, 10.1056/NEJMoa1401914 Lynch, 2009, Streptococcus pneumoniae: epidemiology, risk factors and strategies for prevention, Semin Respir Crit Care Med, 30, 189, 10.1055/s-0029-1202938 Bruggeman, 2007, Vaccine escape recombinants emerge after pneumococcal vaccination in the United States, PLOS Pathog, 3, 1628 2012, Meeting of the Strategic Advisory Group of Experts on Immunization, conclusions and recommendations, Wkly Epidemiol Rec, 87, 1 Dagan, 2008, Impact of conjugate pneumococcal vaccines on antibiotic resistance, Lancet Infect Dis, 8, 785, 10.1016/S1473-3099(08)70281-0 Shibl, 2012, Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA), Vaccine, 30, G32, 10.1016/j.vaccine.2012.07.030 2005, Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease−United States, 1998–2003, MMWR Morb Mortal Wkly Rep, 54, 893 Madhi, 2014, Serotype 3 pneumococcal pleural empyema in an immunocompetent child after 13-valent pneumococcal conjugate vaccine, Pediatr Infect Dis J., 33, 545, 10.1097/INF.0000000000000252 Ho, 2014, Streptococcus pneumoniae serotype 19A bacteremia in a child fully immunized with 10-valent pneumococcal conjugate vaccine, J Microbiol Immunol Infect., 47, 164, 10.1016/j.jmii.2013.09.008 Lu, 2014, Severe Streptococcus pneumoniae 19A pneumonia with empyema in children vaccinated with pneumococcal conjugate vaccines, J Formos Med Assoc.